| dc.rights.license | CC-BY-NC-ND | |
| dc.contributor | None | |
| dc.contributor.advisor | Greve, Maria | |
| dc.contributor.author | Shamali, Mido Al | |
| dc.date.accessioned | 2023-07-27T00:02:41Z | |
| dc.date.available | 2023-07-27T00:02:41Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/44365 | |
| dc.description.abstract | This study showed the benefits of using IPS technology in drug discovery and whether this technology can reduce the timeline, development costs and animal use. | |
| dc.description.sponsorship | Utrecht University | |
| dc.language.iso | EN | |
| dc.subject | This study aims to address the impact of iPS cells in drug discovery by answering the following questions:
• How does the incorporation of iPS cell technology affect the timeline of drug discovery?
• What is the impact of iPS cell technology on development costs compared to traditional approaches?
• How does using iPS cell technology influence the reliance on animal models in drug discovery?
• What are the implications of iPS cell technology on revenue generation and potential investment opportu | |
| dc.title | The Future of Personalized Medicine: iPS cell technology as a Game-Changer in drug discovery | |
| dc.type.content | Master Thesis | |
| dc.rights.accessrights | Open Access | |
| dc.subject.keywords | N.A | |
| dc.subject.courseuu | Science and Business Management | |
| dc.thesis.id | 20349 | |
